These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15989783

  • 1. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity].
    Hao DF, Ma ZH, Wang YP, Rexidan, Zhang FC.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y, Liu Y, Zhang G, Wang A, Dong Z, Qi Y, Wang J, Zhao B, Li N, Jiang M.
    Virus Res; 2016 Jul 15; 220():97-103. PubMed ID: 27107614
    [Abstract] [Full Text] [Related]

  • 4. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
    Hassan SW, Waheed MT, Müller M, Clarke JL, Shinwari ZK, Lössl AG.
    Hum Vaccin Immunother; 2014 Jul 15; 10(10):2975-82. PubMed ID: 25483463
    [Abstract] [Full Text] [Related]

  • 5. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
    Bolhassani A, Shirbaghaee Z, Agi E, Davoudi N.
    Protein Expr Purif; 2015 Dec 15; 116():7-11. PubMed ID: 26304732
    [Abstract] [Full Text] [Related]

  • 6. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 15; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Efficient expression of human papillomavirus type 16 (HPV16) capsid proteins L1 and L2 in E. coli].
    Wang W, Zhou L, Sun Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec 15; 13(4):358-61. PubMed ID: 12759977
    [Abstract] [Full Text] [Related]

  • 9. The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response.
    Bissa M, Zanotto C, Pacchioni S, Volonté L, Venuti A, Lembo D, De Giuli Morghen C, Radaelli A.
    Antiviral Res; 2015 Apr 15; 116():67-75. PubMed ID: 25660110
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
    Tian HW, Ye ZM, Lu ZH, Jao R, Bian T, Zhao L, Ruan L.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun 15; 20(2):33-7. PubMed ID: 16816859
    [Abstract] [Full Text] [Related]

  • 12. [Prokaryotic expression and purification of human papillomavirus type 11 L2E7 fusion protein vaccine and its immunnogenicity].
    Zhang H, Zhao L, Ren J, Gao J, Bian T, Fan JT, Ruan L, Chen XQ, Tian HW.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun 15; 21(2):156-8. PubMed ID: 17653322
    [Abstract] [Full Text] [Related]

  • 13. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
    López-Toledo G, Schädlich L, Alonso-Castro ÁJ, Monroy-García A, García-Rocha R, Guido MC, Gissmann L, García-Carrancá A.
    Viral Immunol; 2016 Jun 15; 29(5):276-87. PubMed ID: 27058179
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of protein expression feature and construction of procaryotic expression system for human papillomavirus type 16 (HPV-16) E4 gene].
    Wang BN, Shi QF, Li H, Zhang WD, Zhuang YH, Yang J, Jiang ZH, Li MY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May 15; 37(3):361-4. PubMed ID: 16761408
    [Abstract] [Full Text] [Related]

  • 15. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
    Schädlich L, Senger T, Kirschning CJ, Müller M, Gissmann L.
    Vaccine; 2009 Mar 04; 27(10):1511-22. PubMed ID: 19174177
    [Abstract] [Full Text] [Related]

  • 16. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
    Pineo CB, Hitzeroth II, Rybicki EP.
    Plant Biotechnol J; 2013 Oct 04; 11(8):964-75. PubMed ID: 23924054
    [Abstract] [Full Text] [Related]

  • 17. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.
    Windram OP, Weber B, Jaffer MA, Rybicki EP, Shepherd DN, Varsani A.
    Arch Virol; 2008 Oct 04; 153(3):585-9. PubMed ID: 18175039
    [Abstract] [Full Text] [Related]

  • 18. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles.
    Patel MC, Patkar KK, Basu A, Mohandas KM, Mukhopadhyaya R.
    Indian J Med Res; 2009 Sep 04; 130(3):213-8. PubMed ID: 19901429
    [Abstract] [Full Text] [Related]

  • 19. [Construction of prokaryotic expression vector of HPV16E6 gene and its expression].
    Peng F, Jiang H, Peng F, Zhao W, Lin Z, Chen Y, Chen S.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug 04; 27(4):847-50. PubMed ID: 20842857
    [Abstract] [Full Text] [Related]

  • 20. Fusion of HPV L1 into Shigella surface IcsA: a new approach in developing live attenuated Shigella-HPV vaccine.
    Xu D, Wang D, Yang X, Cao M, Yu J, Wang Y.
    Antiviral Res; 2014 Feb 04; 102():61-9. PubMed ID: 24333518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.